Both in Pharmaceuticals
AbCellera Biologics vs Liquidia
Over the past year ABCL returned +107.1% and LQDA returned +65.9%; their daily moves had a correlation of 0.12.
ABCL +107.1% LQDA +65.9%Growth of $1, one year, split-adjusted
| Metric | ABCL | LQDA |
|---|---|---|
| Price | $11.12 | $41.85 |
| Market cap | $3.60B | $3.75B |
| Today | −9.37% | −7.12% |
| 1 month | −19.1% | +46.1% |
| 6 months | +142.3% | +8.8% |
| Year to date | +225.1% | +21.3% |
| 1 year | +107.5% | +80.4% |
| Revenue growth (YoY) | −76.3% | +1842.7% |
| Gross margin | 100.0% | 93.3% |
| Net margin | −1368.6% | 43.5% |
| P/E (TTM) | — | 27.0× |
| Price / sales | 54.5× | 8.3× |
| Net cash | $540.1M | $108.1M |
| Dividend yield | — | — |
| Volatility (60d) | 96.9% | 189.7% |
| Short % of float | 14.5% | 26.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).